Impact of Long-Term Oral Antiviral Treatment on Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B Who Are Hepatitis B e Antigen Positive Using the PAGED-B Score

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
May 7-10, 2025
Amsterdam the Netherlands


Impact of Long-Term Oral Antiviral Treatment on Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B Who Are Hepatitis B e Antigen Positive Using the PAGED-B Score

	EASL 2025 May 7-10 Amsterdam